SymBio Pharmaceuticals Limited (TYO:4582)

SymBio Pharmaceuticals Revenue

SymBio Pharmaceuticals had revenue of 324.17M JPY in the quarter ending September 30, 2025, a decrease of -47.20%. This brings the company's revenue in the last twelve months to 1.53B, down -50.27% year-over-year. In the year 2024, SymBio Pharmaceuticals had annual revenue of 2.45B, down -56.13%.

• Revenue (ttm): 1.53B
• Revenue Growth: -50.27%
• P/S Ratio: 3.37
• Revenue / Employee: 14.12M
• Employees: 108
• Market Cap: 5.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.45B	-3.14B	-56.13%
Dec 31, 2023	5.59B	-4.42B	-44.15%
Dec 31, 2022	10.01B	1.75B	21.21%
Dec 31, 2021	8.26B	5.27B	176.42%
Dec 31, 2020	2.99B	149.30M	5.26%